Clinical Trial Update: Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution [Phase 1]

View source ↗

Summary

Phase 1 clinical trial exploring mesenchymal stem cell exosome solution for treatment of congenital myasthenic syndrome; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Myasthenic Syndrome

Drugs mentioned

• Mesenchymal Stem Cell Exosome Solution

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Congenital Myasthenic Syndrome | Phase 1 | Status: RECRUITING